HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combination chemotherapy in the management of superior vena caval obstruction in small-cell anaplastic carcinoma of the lung.

Abstract
Among 225 consecutive patients with small-cell anaplastic bronchogenic carcinoma, 26 (11.5%) had superior vena caval obstruction when the malignancy was diagnosed. Of these 26 patients, a consecutive series of 22 were treated initially with combination chemotherapy (cyclophosphamide, methotrexate and CCNU, in some cases combined with vincristine) alone, and in all these cases resolution of the syndrome was prompt within a median of 7 days. In no case were symptoms increased transiently by the treatment. No difference in response rate was observed between the histologic subtypes of small-cell anaplastic bronchogenic carcinoma according to the WHO classification. Combination chemotherapy alone is an effective treatment of superior vena caval obstruction in patients with small-cell anaplastic bronchogenic carcinoma.
AuthorsP Dombernowsky, H H Hansen
JournalActa medica Scandinavica (Acta Med Scand) Vol. 204 Issue 6 Pg. 513-6 ( 1978) ISSN: 0001-6101 [Print] Sweden
PMID216239 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Vincristine
  • Lomustine
  • Cyclophosphamide
  • Methotrexate
Topics
  • Aged
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Small Cell (complications, drug therapy, radiotherapy)
  • Clinical Trials as Topic
  • Cyclophosphamide (therapeutic use)
  • Drug Evaluation
  • Drug Therapy, Combination
  • Female
  • Humans
  • Lomustine (therapeutic use)
  • Lung Neoplasms (complications, drug therapy, radiotherapy)
  • Lymphatic Metastasis
  • Male
  • Methotrexate (therapeutic use)
  • Middle Aged
  • Vascular Diseases (drug therapy)
  • Vena Cava, Superior
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: